Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
CSL Ltd (CSL) is a leading biotechnology business based in Australia. It opened the day at AUDA$292.6 after a previous close of AUDA$292.5. During the day the price has varied from a low of AUDA$291.95 to a high of AUDA$301.55. The latest price was AUDA$299.34 (25 minute delay). CSL is listed on the Australian Securities Exchange (ASX) and employs 25,000 staff. All prices are listed in Australian Dollars.
Since the stock market crash in March caused by coronavirus, CSL's stock price has had significant negative movement.
Its last market close was A$292.5, which is 13.05% down on its pre-crash value of A$336.4 and 20.53% up on the lowest point reached during the March crash when the stocks fell as low as A$242.67.
If you had bought A$1,000 worth of CSL stocks at the start of February 2020, those stocks would have been worth A$905.99 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth A$938.93.
| Open | A$292.60 |
|---|---|
| High | A$301.55 |
| Low | A$291.95 |
| Close | A$299.34 |
| Previous close | A$292.50 |
| Change | A$6.84 |
| Change % | 2.3385% |
| Volume | 582,882 |
| 52-week range | A$238.78 - A$318.02 |
|---|---|
| 50-day moving average | A$282.39 |
| 200-day moving average | A$277.72 |
| Wall St. target price | A$314.57 |
| PE ratio | 41.35 |
| Dividend yield | A$2.22 (0.97%) |
| Earnings per share (TTM) | A$7.17 |
Historical closes compared with the close of A$299.34 from 2022-08-17
| 1 week (2022-08-10) | 2.39% |
|---|---|
| 1 month (2022-07-18) | 0.90% |
| 3 months (2022-05-18) | 9.61% |
| 6 months (2022-02-18) | 12.72% |
| 1 year (2021-08-18) | 1.97% |
|---|---|
| 2 years (2020-08-18) | 2.06% |
| 3 years (2019-08-16) | 31.64% |
| 5 years (2017-08-17) | 135.70% |
Valuing CSL stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CSL's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CSL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, CSL shares trade at around 41x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CSL's EBITDA (earnings before interest, taxes, depreciation and amortisation) is A$3.4 billion.
The EBITDA is a measure of a CSL's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | A$10.6 billion |
|---|---|
| Operating margin TTM | 28.31% |
| Gross profit TTM | A$5.8 billion |
| Return on assets TTM | 9.13% |
| Return on equity TTM | 20.96% |
| Profit margin | 21.91% |
| Book value | A$29.31 |
| Market capitalisation | A$141.1 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CSL.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 27.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CSL's overall score of 27.73 (as at 01/01/2019) is pretty good – landing it in it in the 40th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CSL is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.04/100
CSL's environmental score of 3.04 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 18.57/100
CSL's social score of 18.57 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 11.12/100
CSL's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CSL is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CSL scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that CSL has, for the most part, managed to keep its nose clean.
Dividend payout ratio: 43.25% of net profits
Recently CSL has paid out, on average, around 43.25% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CSL shareholders could enjoy a 0.97% return on their shares, in the form of dividend payments. In CSL's case, that would currently equate to about A$2.22 per share.
While CSL's payout ratio might seem fairly standard, it's worth remembering that CSL may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 March 2022 (the "ex-dividend date").
CSL's shares were split on a 3:1 basis on 18 October 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CSL shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for CSL shares which in turn could have impacted CSL's share price.
Over the last 12 months, CSL's shares have ranged in value from as little as A$238.7774 up to A$318.0184. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while CSL's is 0.1618. This would suggest that CSL's shares are less volatile than average (for this exchange).
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. .
Steps to owning and managing HKD/USD, with 24-hour and historical pricing before you buy.
An overview of the best investing apps available in NZ, including pros, cons and fees.
Your detailed review of share trading with Rockfort Markets, including fees, safety, and pros and cons.
What’s the best way to invest money in New Zealand? Find out about KiwiSaver, index funds, cryptocurrency and more in this guide.
Your detailed review of share trading with BlackBull Markets, including brokerage fees, safety, pros and cons, and more.
Thinking of trading shares with Jarden Direct? Check out our review of Jarden Direct fees, safety, and pros and cons first.
Your detailed review of online share trading with Tiger Brokers, including fees, markets, safety, pros and cons, and how to sign up.
A growing number of Kiwis are investing in the stock market via an app or online platform, according to research by Finder.
The second Bitcoin future ETF is set to go live Oct. 22. Here’s how to invest if you’re in New Zealand.
Steps to owning and managing VanEck Bitcoin Strategy ETF units.
